Topic Hub
16 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 16 of 16 clinical reviews.
A clinical evidence review of oral micronized progesterone (Prometrium) used off-label for insomnia, including trial data, dosing, safety, and how it compares to standard sleep aids.
Read clinical reviewOral micronized progesterone (Prometrium) is used off-label for insomnia. Learn the evidence, monitoring requirements, dosing, and safety considerations for this sleep aid.
Read clinical reviewEvidence-based guide to using oral micronized progesterone (Prometrium) off-label for insomnia, including dosing protocols, mechanism of action, clinical evidence, and safety considerations.
Read clinical reviewOral micronized progesterone (Prometrium) is used off-label for insomnia due to its GABAergic metabolite allopregnanolone. Learn the evidence, dosing, risks, and how it compares to standard sleep aids.
Read clinical reviewEvidence-based guide to using oral micronized progesterone (Prometrium) off-label for luteal phase support, including dosing, monitoring, and clinical trial data.
Read clinical reviewA clinician-reviewed summary of oral micronized progesterone (Prometrium) used off-label for luteal phase support in ART and natural cycles, covering dosing, evidence quality, and FDA-approved indications.
Read clinical reviewEvidence-based guide to using oral micronized progesterone (Prometrium) off-label for luteal phase support, including dosing protocols, clinical trial data, and safety considerations.
Read clinical reviewCan oral micronized progesterone (Prometrium) support the luteal phase? Review the off-label evidence, dosing protocols, risks, and how it compares to vaginal and injectable progesterone.
Read clinical reviewA clinical evidence summary on using oral micronized progesterone (Prometrium) off-label for perimenopause symptoms including hot flashes, sleep disruption, and irregular bleeding.
Read clinical reviewOral micronized progesterone (Prometrium) is used off-label for perimenopausal symptoms including irregular bleeding, sleep disruption, and vasomotor symptoms. Learn the evidence, recommended doses, and monitoring protocols.
Read clinical reviewEvidence-based guide to using oral micronized progesterone (Prometrium) off-label for perimenopause symptoms, including dosing protocols, clinical evidence, and safety considerations.
Read clinical reviewA clinical deep-dive into off-label oral micronized progesterone (Prometrium) for perimenopause, covering FDA-approved indications, GRADE-rated evidence, dosing, side effects, and when to consider it.
Read clinical reviewA physician-reviewed summary of the evidence for off-label use of oral micronized progesterone (Prometrium) in traumatic brain injury, including ProTECT III, SyNAPSe, GRADE ratings, and current clinical guidance.
Read clinical reviewA clinical review of oral micronized progesterone (Prometrium) for traumatic brain injury, including Phase III trial failures, off-label considerations, neuroprotective mechanisms, and monitoring protocols.
Read clinical reviewA clinician-reviewed look at whether oral micronized progesterone (Prometrium) has a role in traumatic brain injury treatment, what the clinical trials found, and the risks patients and providers should weigh.
Read clinical reviewOral micronized progesterone (Prometrium) has been studied for traumatic brain injury neuroprotection. Review the off-label dosing protocols, Phase III trial results from ProTECT III and SyNAPSe, and current evidence grading.
Read clinical review